Covered recipient · General Payments record
THOTTATHIL GOPAN
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$9,124.32
- Reported across 284 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,297.27 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $244.49 | 2 |
| DEXCOM, INC. | $172.37 | 2 |
| Medtronic, Inc. | $158.75 | 1 |
| Acerta Pharma LLC | $141.61 | 2 |
| BETA BIONICS, INC. | $124.32 | 2 |
| Tandem Diabetes Care, Inc. | $122.71 | 1 |
| Novo Nordisk AS | $120.65 | 1 |
| Insulet Corporation | $117.12 | 1 |
| Xeris Pharmaceuticals, Inc. | $95.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $127.63 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124800474 | CMS |
| Abbott Laboratories | $116.86 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124800476 | CMS |
| AstraZeneca Pharmaceuticals LP | $60.31 | 09/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105447887 | CMS |
| AstraZeneca Pharmaceuticals LP | $81.30 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104714633 | CMS |
| BETA BIONICS, INC. | $73.10 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087880413 | CMS |
| BETA BIONICS, INC. | $51.22 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087886907 | CMS |
| Dexcom, Inc. | $73.10 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153340837 | CMS |
| Dexcom, Inc. | $99.27 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153340839 | CMS |
| Insulet Corporation | $117.12 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116799302 | CMS |
| Medtronic, Inc. | $158.75 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117030034 | CMS |
| Novo Nordisk Inc | $120.65 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096841984 | CMS |
| Tandem Diabetes Care, Inc. | $122.71 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138745221 | CMS |
| Xeris Pharmaceuticals, Inc. | $95.25 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144615909 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.